Controversies 2021 Online Syllabus
General Course Materials
Faculty Slides
Thursday, December 2nd
Faculty slides that were approved by the speaker are linked below.
Faculty slides that were approved by the speaker are linked below.
California ACC Welcome Address
Jamal S. Rana, MD, PhD, FACC
The Ronald G. Victor, MD Memorial Lecture: Cardiology's Biggest Controversy: The Lumen or the Wall
James Forrester, MD, FACC
What Triggers Inflammation in Atherosclerosis?
PK Shah, MD, MACC
Fish Oil: Who Should Get It?
Peter Toth, MD, PhD, FACC
What Diet Is Best for Cardiovascular Health?
Kim Allan Williams, MD, MACC
Keynote Lecture: Upstream Treatment of Aortic Stenosis
Martin Leon, MD, FACC
HRS Guidelines Regarding Digital Health, Telehealth, and Arrhythmia
Christine M. Albert, MD, MPH, FACC
Personalized and Computations Cardiology
Harlan M. Krumholz, MD, SM, FACC
Integration of AI Into Clinical Practice
Rahul Sharma, MBBS, FRACP
Coronary Physiology Is More Important Than Anatomy to Improve Outcomes
William Fearon, MD, FACC
Evaluating Coronary Anatomy Is the Best Way to Improve Outcomes
David Newby, MD, PhD, FACC
Treating Stenosis or Ischemia Does Not Improve Outcomes - Medical Therapy is King
William Boden, MD, FACC, FAHA, FASPC
Optimal Management of Left Main Disease in 2021
Gregg Stone, MD, FACC
A Surgeon's Perspective: Are We Underusing CABG?
Joanna Chikwe, MD, FACC
The Heart Valve Collaboratory
Michael Mack, MD, FACC
Durability of Transcatheter Heart Valves - Has the Dust Settled?
Michael Reardon, MD, FACC
What's New in Transcatheter Mitral and Tricuspid Valve Replacement
Raj Makkar, MD, FACC
Why Is Transcatheter Edge-to-Edge Repair Underutilized in Heart Failure Management? A Discussion
Jubin Joseph, MD, PhD
Echocardiography in the Diagnosis and Management of Mitral Regurgitation
Robert Siegel, MD, FACC
CMR: Pivotal Role in Cardiomyopathy
Michael Salerno, MD, PhD, FACC
Jamal S. Rana, MD, PhD, FACC
The Ronald G. Victor, MD Memorial Lecture: Cardiology's Biggest Controversy: The Lumen or the Wall
James Forrester, MD, FACC
What Triggers Inflammation in Atherosclerosis?
PK Shah, MD, MACC
Fish Oil: Who Should Get It?
Peter Toth, MD, PhD, FACC
What Diet Is Best for Cardiovascular Health?
Kim Allan Williams, MD, MACC
Keynote Lecture: Upstream Treatment of Aortic Stenosis
Martin Leon, MD, FACC
HRS Guidelines Regarding Digital Health, Telehealth, and Arrhythmia
Christine M. Albert, MD, MPH, FACC
Personalized and Computations Cardiology
Harlan M. Krumholz, MD, SM, FACC
Integration of AI Into Clinical Practice
Rahul Sharma, MBBS, FRACP
Coronary Physiology Is More Important Than Anatomy to Improve Outcomes
William Fearon, MD, FACC
Evaluating Coronary Anatomy Is the Best Way to Improve Outcomes
David Newby, MD, PhD, FACC
Treating Stenosis or Ischemia Does Not Improve Outcomes - Medical Therapy is King
William Boden, MD, FACC, FAHA, FASPC
Optimal Management of Left Main Disease in 2021
Gregg Stone, MD, FACC
A Surgeon's Perspective: Are We Underusing CABG?
Joanna Chikwe, MD, FACC
The Heart Valve Collaboratory
Michael Mack, MD, FACC
Durability of Transcatheter Heart Valves - Has the Dust Settled?
Michael Reardon, MD, FACC
What's New in Transcatheter Mitral and Tricuspid Valve Replacement
Raj Makkar, MD, FACC
Why Is Transcatheter Edge-to-Edge Repair Underutilized in Heart Failure Management? A Discussion
Jubin Joseph, MD, PhD
Echocardiography in the Diagnosis and Management of Mitral Regurgitation
Robert Siegel, MD, FACC
CMR: Pivotal Role in Cardiomyopathy
Michael Salerno, MD, PhD, FACC
Friday, December 3rd
Faculty slides that were approved by the speaker are linked below.
Faculty slides that were approved by the speaker are linked below.
Device-Detected Atrial Fibrillation: NOAC or Not?
Roopinder Sandhu, MD, MPH
Clinical Pearls for P.O.T.S. (Postural Orthostatic Tachycardia Syndrome)
Peng-Sheng Chen, MD, FACC
Debate: The Future of Primary Prevention ICDs
• Will Only Benefit Patients with EF <35%
Eric C. Stecker, MD, MPH, FACC
• Will Have the Most Impact in Patients with EF >35%
Sumeet Chugh, MD, FACC
Debate: Aldosterone Blockade vs. Thiazide Diuretics: Which is the Superior Antihypertensive?
• Aldo Blockers and New Trials
Florian Rader, MD, MSc, FACC
• Thiazides, But They Are Not All Created Equal!
Natalie Bello, MD, MPH, FACC
Debate: Race and HTN: True Biologic Difference or Just a Surrogate Marker?
• Main Discussion
Joseph Ebinger, MD, MS, FACC
• What Did We Learn from the Barbershop Trials?
C. Adair Blyler, PharmD, CHC
Debate: Out-of-Office Blood Pressure Monitoring for the Managementof Hypertension
• Home and Ambulatory BP Monitoring Are Essential Tools
Michael Weber, MD, FACC
• Ambulatory BP Monitoring is an Antiquated and Impractical Tool
Raj Khandwalla, MD, MA, FACC
Update on Practice-Changing CV Trials of 2021
Sanjay Kaul, MD, MPH, FACC
Keynote Lecture: How Should We Define and Achieve Equity in Health Care?
Harlan M. Krumholz, MD, SM, FACC
Keynote Lecture: Heart Disease in Pregnancy
Athena Poppas, MD, MACC
Sodium-Glucose Co-Transporter 2 (SGLT2) and Heart Failure
Michelle Kittleson, MD, PhD, FACC
Cardiac iBox to Predict Outcomes in Heart Transplant Patients
Jignesh Patel, MD, PhD, FACC
Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation
• Michelle Kittleson, MD, PhD, FACC
• John Mandrola, MD, FACC
Investigating Patients with Suspected Stable Angina: Beyond ISCHEMIA
C. Noel Bairey Merz, MD, FACC
Roopinder Sandhu, MD, MPH
Clinical Pearls for P.O.T.S. (Postural Orthostatic Tachycardia Syndrome)
Peng-Sheng Chen, MD, FACC
Debate: The Future of Primary Prevention ICDs
• Will Only Benefit Patients with EF <35%
Eric C. Stecker, MD, MPH, FACC
• Will Have the Most Impact in Patients with EF >35%
Sumeet Chugh, MD, FACC
Debate: Aldosterone Blockade vs. Thiazide Diuretics: Which is the Superior Antihypertensive?
• Aldo Blockers and New Trials
Florian Rader, MD, MSc, FACC
• Thiazides, But They Are Not All Created Equal!
Natalie Bello, MD, MPH, FACC
Debate: Race and HTN: True Biologic Difference or Just a Surrogate Marker?
• Main Discussion
Joseph Ebinger, MD, MS, FACC
• What Did We Learn from the Barbershop Trials?
C. Adair Blyler, PharmD, CHC
Debate: Out-of-Office Blood Pressure Monitoring for the Managementof Hypertension
• Home and Ambulatory BP Monitoring Are Essential Tools
Michael Weber, MD, FACC
• Ambulatory BP Monitoring is an Antiquated and Impractical Tool
Raj Khandwalla, MD, MA, FACC
Update on Practice-Changing CV Trials of 2021
Sanjay Kaul, MD, MPH, FACC
Keynote Lecture: How Should We Define and Achieve Equity in Health Care?
Harlan M. Krumholz, MD, SM, FACC
Keynote Lecture: Heart Disease in Pregnancy
Athena Poppas, MD, MACC
Sodium-Glucose Co-Transporter 2 (SGLT2) and Heart Failure
Michelle Kittleson, MD, PhD, FACC
Cardiac iBox to Predict Outcomes in Heart Transplant Patients
Jignesh Patel, MD, PhD, FACC
Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation
• Michelle Kittleson, MD, PhD, FACC
• John Mandrola, MD, FACC
Investigating Patients with Suspected Stable Angina: Beyond ISCHEMIA
C. Noel Bairey Merz, MD, FACC